Compugen Ltd. To Present Cancer Immunotherapy Programs At Three International Cancer Conferences In March

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Compugen Ltd. (NASDAQ: CGEN) today announced that its scientists are presenting at three international cancer conferences next month:

Cancer Progress, March 4-5, 2014 in New York, NY

Galit Rotman, PhD, Chief Scientist of Therapeutics, Compugen: Taking Immunotherapy Seriously: New Targets and Combinations

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC